Literature DB >> 19056247

Regional dopamine synthesis in patients with schizophrenia using L-[beta-11C]DOPA PET.

Shoko Nozaki1, Motoichiro Kato, Harumasa Takano, Hiroshi Ito, Hidehiko Takahashi, Ryosuke Arakawa, Masaki Okumura, Yota Fujimura, Ryohei Matsumoto, Miho Ota, Akihiro Takano, Akihiko Otsuka, Fumihiko Yasuno, Yoshiro Okubo, Haruo Kashima, Tetsuya Suhara.   

Abstract

The dopamine hypothesis has been the most widely known theory concerning schizophrenia. However, the exact mechanism including presynaptic dopaminergic activity and its relationship with symptom severity still remains to be revealed. We measured presynaptic dopamine synthesis using positron emission tomography (PET) with L-[beta-(11)C]DOPA in 18 patients with schizophrenia (14 drug-naive and 4 drug-free patients) and 20 control participants. Dopamine synthesis rates, expressed as k(i) values, were obtained using a graphical method, and the occipital cortex was used as reference region. Regions of interest were placed on the prefrontal cortex, temporal cortex, anterior cingulate, parahippocampus, thalamus, caudate nucleus, and putamen. Psychopathology was assessed with the Positive and Negative Symptom Scale (PANSS). We found significantly higher k(i) values in patients than in controls in the left caudate nucleus, but not in the other regions. The k(i) values in the thalamus exhibited a significant positive correlation with the PANSS total scores. Furthermore, a significant positive correlation was observed between the PANSS positive subscale scores and k(i) values in the right temporal cortex. Patients with schizophrenia showed higher dopamine synthesis in the left caudate nucleus, and dopaminergic transmission in the thalamus and right temporal cortex might be implicated in the expression of symptoms in schizophrenia.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 19056247     DOI: 10.1016/j.schres.2008.11.006

Source DB:  PubMed          Journal:  Schizophr Res        ISSN: 0920-9964            Impact factor:   4.939


  26 in total

1.  Striatal presynaptic dopamine in schizophrenia, part II: meta-analysis of [(18)F/(11)C]-DOPA PET studies.

Authors:  Paolo Fusar-Poli; Andreas Meyer-Lindenberg
Journal:  Schizophr Bull       Date:  2012-01-26       Impact factor: 9.306

2.  Interactions between glutamate, dopamine, and the neuronal signature of response inhibition in the human striatum.

Authors:  Robert C Lorenz; Tobias Gleich; Ralph Buchert; Florian Schlagenhauf; Simone Kühn; Jürgen Gallinat
Journal:  Hum Brain Mapp       Date:  2015-07-14       Impact factor: 5.038

3.  Presynaptic Dopamine Capacity in Patients with Treatment-Resistant Schizophrenia Taking Clozapine: An [18F]DOPA PET Study.

Authors:  Euitae Kim; Oliver D Howes; Mattia Veronese; Katherine Beck; Seongho Seo; Jin Woo Park; Jae Sung Lee; Yun-Sang Lee; Jun Soo Kwon
Journal:  Neuropsychopharmacology       Date:  2016-11-18       Impact factor: 7.853

4.  The interrelationship of dopamine D2-like receptor availability in striatal and extrastriatal brain regions in healthy humans: a principal component analysis of [18F]fallypride binding.

Authors:  David H Zald; Neil D Woodward; Ronald L Cowan; Patrizia Riccardi; M Sib Ansari; Ronald M Baldwin; Ronald L Cowan; Clarence E Smith; Helene Hakyemez; Rui Li; Robert M Kessler
Journal:  Neuroimage       Date:  2010-02-10       Impact factor: 6.556

5.  Possible role of the dopamine D1 receptor in the sensorimotor gating deficits induced by high-fat diet.

Authors:  Chisato Wakabayashi; Tadahiro Numakawa; Yoshiko Ooshima; Kotaro Hattori; Hiroshi Kunugi
Journal:  Psychopharmacology (Berl)       Date:  2015-09-11       Impact factor: 4.530

Review 6.  Presynaptic dopamine in schizophrenia.

Authors:  Nobumi Miyake; Judy Thompson; Mette Skinbjerg; Anissa Abi-Dargham
Journal:  CNS Neurosci Ther       Date:  2010-12-27       Impact factor: 5.243

Review 7.  Basal ganglia pathology in schizophrenia: dopamine connections and anomalies.

Authors:  Emma Perez-Costas; Miguel Melendez-Ferro; Rosalinda C Roberts
Journal:  J Neurochem       Date:  2010-01-20       Impact factor: 5.372

Review 8.  Executive function, neural circuitry, and genetic mechanisms in schizophrenia.

Authors:  Daniel Paul Eisenberg; Karen Faith Berman
Journal:  Neuropsychopharmacology       Date:  2010-01       Impact factor: 7.853

9.  Influence of O-methylated metabolite penetrating the blood-brain barrier to estimation of dopamine synthesis capacity in human L-[β-(11)C]DOPA PET.

Authors:  Keisuke Matsubara; Yoko Ikoma; Maki Okada; Masanobu Ibaraki; Tetsuya Suhara; Toshibumi Kinoshita; Hiroshi Ito
Journal:  J Cereb Blood Flow Metab       Date:  2013-11-06       Impact factor: 6.200

Review 10.  Pathway-Specific Dopamine Abnormalities in Schizophrenia.

Authors:  Jodi J Weinstein; Muhammad O Chohan; Mark Slifstein; Lawrence S Kegeles; Holly Moore; Anissa Abi-Dargham
Journal:  Biol Psychiatry       Date:  2016-03-31       Impact factor: 13.382

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.